Relationship between lipoprotein(a) and fasting plasma glucose in the general population

European Journal of Clinical Investigation

Volumn 37, Issue 10, 2007, Pages 826-827

  Lippi, G ^a,b   Targher, G ^a   Salvagno, G L ^a   Montagnana, M ^a   Guidi, G C ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

Diabetes; Fasting plasma glucose; Impaired glucose tolerance; Lipoprotein(a)

Indexed keywords

GLUCOSE; LIPOPROTEIN A;

BLOOD BRAIN BARRIER; DIABETES MELLITUS; GENERAL PRACTITIONER; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LETTER; NEPHELOMETRY; PRIORITY JOURNAL;

AGED; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; FASTING; FEMALE; HUMANS; LIPOPROTEIN(A); MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 34748861830     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2007.01860.x     Document Type: Letter

References (8)

1. Kostner KM, Kostner GM. Lipoprotein (a): still an enigma? Curr Opin Lipidol 2002 13 : 391 6.
2. Kronenberg F, Steinmetz A, Kostner GM, Dieplinger H. Lipoprotein (a) in health and disease. Crit Rev Clin Lab Sci 1996 33 : 495 543.
3. Lippi G, Guidi G. Lipoprotein (a): an emerging cardiovascular risk factor. Crit Rev Clin Lab Sci 2003 40 : 1 42.
4. Kostner KM. Does lipoprotein (a) predict risk in type 2 diabetes? Eur J Clin Invest 2006 36 : 67 8.
5. Saely CH, Koch L, Schmid F, Marte T, Aczel S, Langer P et al. Lipoprotein (a), type 2 diabetes and vascular risk in coronary patients. Eur J Clin Invest 2006 36 : 91 7.
6. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2006 29 (Suppl. 1 S43 8.
7. Labudović DD, Toseska KN, Alabakovska SB, Dimitrovski C, Jurhar M, Isjanovska R et al. Frequency distribution of apoprotein (a) isoforms in patients with diabetes mellitus and healthy subjects. Croat Med J 2003 44 : 435 40.
8. Hirata K, Saku K, Jimi S, Kikuchi S, Hamaguchi H, Arakawa K. Serum lipoprotein (a) concentrations and apolipoprotein (a) phenotypes in the families of NIDDM patients. Diabetologia 1995 38 : 1434 42.